Prolacta Bioscience
Latest round
- Series D
Last raised
- Nov 2011
Total raised
- $36M
Investors
- 13
About Prolacta Bioscience
Prolacta Bioscience Inc.Founded in 1999 and headquartered in City of Industry, US, Prolacta Bioscience specializes in human milk-based nutritional solutions. The company has not undergone any notable pivots or changes in operations.Prolacta Bioscience specializes in the development and manufacturing of human milk-based fortifiers specifically designed for neonatal intensive care units (NICUs). Their flagship product, Surgifort®, is the first and only 100% human milk-based fortifier approved by the US FDA for term infants with gastroschisis who have undergone corrective surgical procedures. The company’s products aim to enhance feeding tolerance and support adequate growth for preterm and critically ill infants while minimizing complications such as necrotizing enterocolitis (NEC).Prolacta Bioscience generates revenue through direct sales of its human milk-based fortifiers and nutritional products to hospitals and healthcare facilities. Their transaction structure typically involves B2B agreements, ensuring that hospitals procure products for their NICUs. The sales process is supported by clinician-to-clinician guidance and partnerships that enhance the implementation of optimal feeding protocols.Prolacta Bioscience aims to expand its product offerings and enhance its market presence. While specific upcoming products have not been detailed, the company is focusing on developing innovative nutritional solutions for infants. Plans for geographic expansion include targeting new markets beyond its current stronghold in North America, Europe, and Australia, with a strategic timeline aiming for increased presence in emerging markets by the end of 2025.00 mn will support these initiatives, allowing for investment in product development and market entry strategies.
Who invested in Prolacta Bioscience
13 investors across 4 rounds
See all investors in Prolacta Bioscience
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Prolacta Bioscience
Who invested in Prolacta Bioscience?
Prolacta Bioscience has 13 investors on record across 4 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Prolacta Bioscience raised?
Prolacta Bioscience has raised 4 venture rounds. Sign up free to see how much each round raised and the total.
When did Prolacta Bioscience last raise money?
Prolacta Bioscience's most recent round on record is a Series D, in Nov 2011.
What does Prolacta Bioscience do?
Prolacta Bioscience is a biotechnology company.
Where is Prolacta Bioscience headquartered?
Prolacta Bioscience is headquartered in City of Industry, US.
Which VCs invest in companies like Prolacta Bioscience?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Prolacta Bioscience's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series D
Raising like Prolacta Bioscience? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.